Skip to content
10-Q

Quarterly Report

Apexigen, Inc.

0001193125-22-224171

← back to feed
Filed
Aug 18, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 17, 2022 21.45M sh
Stock Repurchased Q2 2022 · Jun 30, 2022 $6.96M
Stock Repurchased Q2 2022 · Jun 30, 2021 $0
Current Liabilities Q2 2022 · Jun 30, 2022 $4.82M
Current Liabilities Q2 2022 · Dec 31, 2021 $186.7K
Total Liabilities Q2 2022 · Jun 30, 2022 $4.83M
Total Liabilities Q2 2022 · Dec 31, 2021 $236.36K
Current Assets Q2 2022 · Jun 30, 2022 $120.02K
Current Assets Q2 2022 · Dec 31, 2021 $230.83K
Total Assets Q2 2022 · Jun 30, 2022 $51.82M
Total Assets Q2 2022 · Dec 31, 2021 $58.32M
Net Income Q2 2022 · Mar 31, 2022 −$2.46M
Net Income Q2 2022 · Jun 30, 2021 −$281.58K
Net Income Q2 2022 · Jun 30, 2021 −$451.58K
Net Income Q2 2022 · Mar 31, 2021 −$170K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$316.8K
Stockholders Equity restated Q2 2022 · Jun 30, 2021 $37.28K
Stockholders Equity restated Q2 2022 · Mar 31, 2021 $318.86K
Stockholders Equity Q2 2022 · Dec 31, 2020 $24.15K
Sga Expense Q2 2022 · Jun 30, 2021 $113.08K
Sga Expense Q2 2022 · Jun 30, 2021 $194.62K
Operating Income Q2 2022 · Jun 30, 2021 −$163.52K
Operating Income Q2 2022 · Jun 30, 2021 −$286.21K